POMC and obesity disorder: In agreement with our results, it has been recently reported that treatments like proanthocyanidins, which reduce obesity-induced hypothalamic inflammation and leptin resistance, are associated with decreased caloric intake and increased gene expression of POMC in the hypothalamus [40].